Clinical Trial Update: Prognostic Impact of Guideline-recommended Timing for Invasive Strategy in NSTEMI

View source ↗

Summary

A completed clinical trial evaluating the prognostic impact of guideline-recommended timing for invasive strategy in non-ST-elevation myocardial infarction and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-st-elevation Acute Coronary Syndrome
• Non-st-elevation Myocardial Infarction
• Unstable Angina

Snippet

Sponsor: University Hospital, Montpellier | Conditions: NSTEMI, NSTE-ACS (NSTEMI and UA) | Status: COMPLETED